Adoptive Cell Immunotherapy for Cancer
We are dedicated to the research of cellular therapy for cancer with a focus on Adoptive T cell Transfer. The goal of our work is to produce antigen-specific T cells with desired functions and to generate them under conditions that allow their use in the clinic. The desired function of these T cells for cancer therapy should be their ability to eliminate cancer cells through recognition of multiple tumor-associated antigens (TAAs), to migrate into tumors, and to have a phenotype that ensures their persistence after transfer to the patient. Our studies are focused on prostate cancer and renal cell carcinoma. The topic is part of the research of the Tumor Immunology Group
